Bradley_Hasson

Bradley Hasson

MilliporeSigma

Bradley Hasson is the Director of Lab Operations for Next Generation Sequencing Services at MilliporeSigma. Brad leads a team of Scientists, laboratory technicians and bioinformaticians that perform NGS-based biosafety testing services in support of product characterization and release worldwide. He has 15 years of experience developing and implementing molecular-based methods for the purposes of lot release and characterization testing in a variety of biologically derived products


Appearances

  • Thumbnail for Identity testing by NGS as a means of risk mitigation
    Date
    June 8, 2022
    Imagine that you just completed a manufacturing run for a mission critical gene therapy vector. All of your release testing is underway, and you are days away from releasing your product. Per regulatory guidelines, identity testing is performed to confirm the vector sequence is as expected…

    Speaker

    Speaker Image for Bradley Hasson
    MilliporeSigma